Lymphokine-activated killer cell lysis of human neuroblastoma cells: A model for purging tumor cells from bone marrow
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 46 (1) , 150-156
- https://doi.org/10.1016/0090-1229(88)90015-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Natural cytolytic activity in mice with natural or induced cellular defectsCellular Immunology, 1986
- Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantationBlood, 1986
- Identification of functional subpopulations of murine natural killer cells based on their cell surface asialo GM1 phenotypeCellular Immunology, 1985
- Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalanBritish Journal of Haematology, 1984
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Potentiation of Leu 11+ natural cytotoxicity by human interleukin 2Clinical Immunology and Immunopathology, 1984
- REMOVAL OF NEUROBLASTOMA CELLS FROM BONE MARROW WITH MONOCLONAL ANTIBODIES CONJUGATED TO MAGNETIC MICROSPHERESThe Lancet, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- DISSEMINATED MALIGNANT MELANOMAThe Lancet, 1959